Table I Index
Table of Contents
|
Table I - 9 Cass Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 191 | 357.3 | 93 | 413.3 | 98 | 328.8 |
| Oral cavity and pharynx | 5 | 10.9** | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 33 | 54.2 | 16 | 69.3** | 17 | 48.5** |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 19 | 31.7** | 7 | 30.9** | 12 | 34.8** |
| Rectum and rectosigmoid | 6 | 9.2** | * | # | * | # |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | * | # | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 43 | 82.3 | 28 | 123.6 | 15 | 57.1** |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | 6 | 13.3** | 5 | 23.3** | * | # |
| Lung and bronchus | 37 | 68.9 | 23 | 100.3 | 14 | 52.3** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 7 | 12.0** | * | # | * | # |
| Melanoma of the skin | 7 | 12.0** | * | # | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 24 | 46.4 | * | # | 24 | 84.9 |
| Female genital system | 17 | 31.0** | -- | -- | 17 | 55.7** |
| Cervix uteri | 5 | 10.8** | -- | -- | 5 | 21.2** |
| Corpus uteri | * | # | -- | -- | * | # |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 6 | 9.9** | -- | -- | 6 | 16.5** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 23 | 44.5 | 23 | 102.2 | -- | -- |
| Prostate gland | 21 | 41.1 | 21 | 94.1 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 14 | 25.4** | 10 | 45.0** | * | # |
| Urinary bladder | 8 | 13.1** | 6 | 26.2** | * | # |
| Kidney and renal pelvis | 6 | 12.3** | * | # | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | * | # | * | # | * | # |
| Brain | * | # | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 12 | 24.3** | 5 | 24.4** | 7 | 22.2** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 10 | 20.0** | * | # | 6 | 18.7** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | * | # | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 5 | 7.4** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||